Title
Challenges in Endoscopic Therapy of Dysplastic Barrett's Esophagus.
Publication Date
2019
Journal Title
Curr Treat Options Gastroenterol
Abstract
PURPOSE OF REVIEW:Barrett's esophagus (BE) is the only known measurable factor associated with esophageal adenocarcinoma. The development of endoscopic eradication therapy (EET) has transformed the way BE is managed. Given the fairly recent development of EET, its role in BE is still evolving. RECENT FINDINGS:This paper discusses the challenges that endoscopists face at the preprocedural, intraprocedural, and postprocedural stages of BE management. These include challenges in risk stratification, dysplasia detection, ablation methods and dosimetry, choice of resection technique, and management of refractory disease. Despite the advances in EET in BE, there remain challenges that this review focuses on. Future research into these challenges will optimize ablation techniques and strategies in the future.
Volume Number
17
Issue Number
1
Pages
32 - 47
Document Type
Article
Status
Faculty; Northwell Resident
Facility
School of Medicine; Northwell Health
Primary Department
Gastroenterology
PMID
DOI
10.1007/s11938-019-00215-8